Ferring Pharmaceuticals Provides Baby Quest Foundation Grant Recipients with Free Access to Fertility Medication
PARSIPPANY, N.J., Aug. 20, 2013 /PRNewswire-USNewswire/ -- In a continued effort to support patients facing infertility, Ferring Pharmaceuticals Inc. today announced a donation to Baby Quest Foundation, Inc. – a non-profit organization focused on providing financial assistance to patients pursuing fertility treatment. Through this collaboration, Ferring will provide 10 Baby Quest grant recipients with free access to select fertility medications, enabling them to undergo one full IVF cycle, with the hopes of helping them achieve their dream of parenthood.
It is estimated that about 6.7 million women between the ages of 15 to 44 in the U.S. experience infertility or the inability to carry a baby to term. [i]
"Each year, millions of families struggle with getting pregnant," said Justin Rauschkolb, Manager of Product Promotions of Ferring's reproductive health unit. "Through our work with Baby Quest, we aspire to help some of these patients build and grow their families, while also providing hope for others still on the journey to becoming parents."
Ferring and Baby Quest kicked off their partnership at NASDAQ, where Baby Quest co-founder Pamela Hirsch and team rang the opening bell.
"We are so thankful for the generosity of Ferring Pharmaceuticals in donating medication so that our grant recipients can pursue infertility treatment," said Hirsch. "Their donation allows us to continue our work of increasing public awareness of the condition of infertility and of providing financial assistance to those who cannot afford the high costs of fertility treatments."
Ferring, as a company, has a commitment to helping patients realize their dream of parenthood. In addition to their work with Baby Quest, Ferring has other initiatives supporting both patients facing infertility and the community including:
- Heart Beat Patient Assistance Program – Offers financial assistance for eligible patients pursuing fertility preservation services prior to cancer treatment. For more information, visit www.ferringfertility.com/savings/heartbeat.
- 2013 Heart to Heart Video Contest – Allows participants the chance to win up to $15,000 toward their child's education for submitting a video essay telling the story of their steps on the path to parenthood. For more information or to submit a video by the August 31st deadline, visit www.hearttoheartcontest.com.
- Local Playground Adoption – The Reproductive Health Unit of Ferring's Parsippany office adopted a local playground as a part of the Morristown "Adopt-a-Spot" program and Ferring's "Living the Philosophy" initiative, which grants employees one day per quarter to dedicate to service. Ferring will be responsible for upkeep of the park throughout the year. For more information about Ferring's community involvement, visit www.ferringusa.com/about/community.
To learn more about Ferring's initiatives in reproductive health, visit www.ferringfertility.com.
About Ferring Pharmaceuticals Inc.
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and osteoarthritis. For more information, visit www.ferringUSA.com.
[i]"Infertility." Centers for Disease Control and Prevention. 2013. http://www.cdc.gov/nchs/fastats/fertile.htm.
SOURCE Ferring Pharmaceuticals Inc.
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.